A detailed history of Wfa Of San Diego, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wfa Of San Diego, LLC holds 2,296 shares of ABBV stock, worth $411,994. This represents 0.39% of its overall portfolio holdings.

Number of Shares
2,296
Previous 2,296 -0.0%
Holding current value
$411,994
Previous $393,000 15.27%
% of portfolio
0.39%
Previous 0.36%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $11,764 - $13,737
-76 Reduced 3.2%
2,296 $393,000
Q3 2023

Nov 02, 2023

SELL
$133.59 - $154.65 $5,343 - $6,186
-40 Reduced 1.66%
2,372 $353,000
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $73,543 - $91,519
-555 Reduced 18.71%
2,412 $324,000
Q1 2023

Apr 17, 2023

SELL
$144.61 - $166.54 $43,383 - $49,962
-300 Reduced 9.18%
2,967 $472,000
Q2 2022

Jul 28, 2022

SELL
$137.62 - $174.96 $43,350 - $55,112
-315 Reduced 8.79%
3,267 $500,000
Q1 2022

Apr 25, 2022

SELL
$131.98 - $163.75 $65,990 - $81,875
-500 Reduced 12.25%
3,582 $581,000
Q4 2021

Feb 07, 2022

BUY
$107.43 - $135.93 $40,823 - $51,653
380 Added 10.26%
4,082 $553,000
Q3 2021

Oct 25, 2021

SELL
$106.4 - $120.78 $11,704 - $13,285
-110 Reduced 2.89%
3,702 $399,000
Q2 2021

Aug 11, 2021

SELL
$105.21 - $117.21 $13,151 - $14,651
-125 Reduced 3.18%
3,812 $429,000
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $402,755 - $443,384
3,937 New
3,937 $426,000
Q4 2020

Feb 11, 2021

SELL
$80.49 - $108.67 $362,365 - $489,232
-4,502 Closed
0 $0
Q3 2020

Nov 06, 2020

SELL
$85.91 - $100.83 $43,814 - $51,423
-510 Reduced 10.18%
4,502 $394,000
Q2 2020

Aug 27, 2020

SELL
$73.37 - $98.18 $8,070 - $10,799
-110 Reduced 2.15%
5,012 $492,000
Q2 2020

Aug 18, 2020

BUY
$73.37 - $98.18 $375,801 - $502,877
5,122 New
5,122 $451,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wfa Of San Diego, LLC Portfolio

Follow Wfa Of San Diego, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wfa Of San Diego, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wfa Of San Diego, LLC with notifications on news.